The Future of Cognitive Screening in Neurodegenerative Diseases
Journal of Alzheimer's Disease · 2023
DOI: 10.3233/jad-221077 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Alzheimer's Disease, 2023. Verfasst von Laura Glass Umfleet und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Medical College of Wisconsin, Wauwatosa, WI, USA. Hauptthemen laut MEDLINE: Neurodegenerative Diseases, Dementia, Cognitive Dysfunction, Alzheimer Disease. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 102 Literaturangaben. Gefördert von: NIMH NIH HHS, NIA NIH HHS.
Abstract (Originalsprache)
Cognitive screening instruments (CSI) have variable sensitivity and specificity to the cognitive changes associated with dementia syndromes, and the most recent systematic review found insufficient evidence to support the benefit of cognitive screening tools in older adults residing within the community. Consequently, there is a critical need to improve CSI methods, which have not yet incorporated advances in psychometrics, neuroscience, and technology. The primary goal of this article is to provide a framework for transitioning from legacy CSIs to advanced dementia screening measurement. In line with ongoing efforts in neuropsychology and the call for next-generation digital assessment for early detection of AD, we propose a psychometrically advanced (including application of item response theory methods), automated selective assessment model that provides a framework to help propel an assessment revolution. Further, we present a three-phase model for modernizing CSIs and discuss critical diversity and inclusion issues, current challenges in differentiating normal from pathological aging, and ethical considerations.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Neurology, Medical College of Wisconsin, Wauwatosa, WI, USA.
- Department of Psychiatry and Biobehavioral Sciences, University of California, Los Angeles, CA, USA.
- Department of Neurology, Emory University School of Medicine, Atlanta, GA, USA.
- Department of Pediatrics, Emory University School of Medicine, Atlanta, GA, USA.
- Department of Psychiatry, University of Michigan, Ann Arbor, MI, USA.
- Mental Health Service, VA Ann Arbor Healthcare System, Ann Arbor, MI, USA.
Förderung
- NIMH NIH HHS
- NIA NIH HHS
Zitieren
APA
Umfleet, L. G., Bilder, R. M., Loring, D. W., Thames, A., Hampstead, B. M., Bauer, R. M., Drane, D. L., & Cavanagh, L. (2023). The Future of Cognitive Screening in Neurodegenerative Diseases. Journal of Alzheimer's Disease. https://doi.org/10.3233/jad-221077
Vancouver
Umfleet LG, Bilder RM, Loring DW, Thames A, Hampstead BM, Bauer RM, et al. The Future of Cognitive Screening in Neurodegenerative Diseases. Journal of Alzheimer's Disease. 2023. doi:10.3233/jad-221077
BibTeX
@article{Umfleet2023,
author = {Umfleet, Laura Glass and Bilder, Robert M and Loring, David W and Thames, April and Hampstead, Benjamin M and Bauer, Russell M and Drane, Daniel L and Cavanagh, Lucia},
title = {The Future of Cognitive Screening in Neurodegenerative Diseases},
journal = {Journal of Alzheimer's Disease},
year = {2023},
doi = {10.3233/jad-221077}
}
EUVIMED